Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 7 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Cyclophosphamide 2040 Radiotherapy 1854 Cisplatin 1820 Carboplatin 1530 Gemcitabine 1432 Paclitaxel 1289 Bevacizumab 1267 Docetaxel 1200 pembrolizumab 1196 Oxaliplatin 1157 Capecitabine 1140 Fluorouracil 1059 Dexamethasone 971 Rituximab 918 Nivolumab 908 Magnetic Resonance Spectroscopy 858 Etoposide 839 Doxorubicin 823 Drug Therapy 789 Radiosurgery 774 Irinotecan 774 Cytarabine 736 fludarabine 714 Leucovorin 674 Lenalidomide 608 fludarabine phosphate 564 Temozolomide 552 Filgrastim 540 Radiation 539 Cetuximab 535

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × zilucoplan × Clear all

NCT07215949 2026-02-23

Zilucoplan for Severe gMG Exacerbations

Ohio State University

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡